Primary brain tumors are a heterogeneous group of malignancies that originate in cells of
the central nervous system. A variety of models tractable for preclinical studies have been …

Immunotherapy has emerged as a promising approach to treat cancer, however, its efficacy
in highly malignant brain-tumors, glioblastomas (GBM), is limited. Here, we generate distinct …

Immunotherapy for brain tumors remains elusive, unlike many other cancer types for which it
is one of the most promising therapeutic options. Recent studies have comprehensively …

YOHYSYJDKVYCJI-UHFFFAOYSA-N n-[3-[[6-[3-(trifluoromethyl) anilino] pyrimidin-4-yl]
amino] phenyl] cyclopropanecarboxamide Chemical compound FC (F)(F) C1= CC= CC …

Primary brain tumors are a heterogeneous group of malignancies that originate in cells of
the central nervous system. A variety of models tractable for preclinical studies have been …

WO2019104037A1 - Msc-expressed immunomodulators in combination with car-t for
cancer therapy - Google Patents WO2019104037A1 - Msc-expressed immunomodulators in …

Bu tez çalışması kapsamında, Isı şok protein 10 (Hsp10)'un Mezenkimal kök hücrelerin
(MKH) immünomodülasyonundaki rolü araştırıldı. Hücrelerin karakterizasyonu için stromal …